Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Foletti

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireYik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
Molecular Cancer Therapeutics|March 6, 2016
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker DesignMagdalena Dorywalska, Russell Dushin, Ludivine Moine, et al.
Journal of Molecular Biology|October 7, 2014
Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencingThomas Van Blarcom, Andrea Rossi, Davide Foletti, et al.
Scientific Reports|November 9, 2019
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Scientific Reports|June 12, 2019
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Bioconjugate Chemistry|February 3, 2015
Effect of attachment site on stability of cleavable antibody drug conjugatesMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Plos One|July 11, 2015
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC EfficacyMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Scientific Reports|March 4, 2025
Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertensionShan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Scientific Reports|June 8, 2024
Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertensionShan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Communications|November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireYik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
Molecular Cancer Therapeutics|March 6, 2016
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker DesignMagdalena Dorywalska, Russell Dushin, Ludivine Moine, et al.
Journal of Molecular Biology|October 7, 2014
Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencingThomas Van Blarcom, Andrea Rossi, Davide Foletti, et al.
Scientific Reports|November 9, 2019
Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Scientific Reports|June 12, 2019
Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic CancerGuoyun Zhu, Davide Foletti, Xiaohui Liu, et al.
Bioconjugate Chemistry|February 3, 2015
Effect of attachment site on stability of cleavable antibody drug conjugatesMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Plos One|July 11, 2015
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC EfficacyMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.
Scientific Reports|March 4, 2025
Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertensionShan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Scientific Reports|June 8, 2024
Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertensionShan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Pageof 2